Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-097471
Filing Date
2016-02-16
Accepted
2016-02-16 18:18:44
Documents
1
Period of Report
2016-02-11

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4029
  Complete submission text file 0001104659-16-097471.txt   5461
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400E CAMBRIDGE MA 02139
Business Address
Cunnane Deirdre A. (Reporting) CIK: 0001666942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 161430844